Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Domenico Franco Merlo

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
European Journal of Nutrition|September 23, 2016
Maternal diet during pregnancy and micronuclei frequency in peripheral blood T lymphocytes in mothers and newborns (Rhea cohort, Crete)Cristina O'Callaghan-Gordo, Manolis Kogevinas, Marie Pedersen, et al.
The Lancet. Oncology|May 14, 2017
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trialAlessandro Gronchi, Stefano Ferrari, Vittorio Quagliuolo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2020
Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma GroupsAlessandro Gronchi, Emanuela Palmerini, Vittorio Quagliuolo, et al.
Molecular Cancer Therapeutics|September 23, 2021
Predictive Value of MRP-1 in Localized High-Risk Soft Tissue Sarcomas: A Translational Research Associated to ISG-STS 1001 Randomized Phase III TrialJavier Martin-Broto, Maria Lopez-Alvarez, David S Moura, et al.
Cancer|October 13, 2021
Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trialSandro Pasquali, Emanuela Palmerini, Vittorio Quagliuolo, et al.
Italian Journal of Pediatrics|December 26, 2014
SETIL: Italian multicentric epidemiological case-control study on risk factors for childhood leukaemia, non hodgkin lymphoma and neuroblastoma: study population and prevalence of risk factors in ItalyCorrado Magnani, Stefano Mattioli, Lucia Miligi, et al.
JAMA Internal Medicine|October 20, 2020
Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical TrialCarlo Salvarani, Giovanni Dolci, Marco Massari, et al.
American Journal of Industrial Medicine|October 19, 2023
Cause specific mortality in an Italian pool of asbestos workers cohortsDaniela Ferrante, Alessia Angelini, Fabiano Barbiero, et al.
The European Respiratory Journal|April 1, 2022
Intravenous methylprednisolone pulses in hospitalised patients with severe COVID-19 pneumonia: a double-blind, randomised, placebo-controlled trialCarlo Salvarani, Marco Massari, Massimo Costantini, et al.
Environmental Health Perspectives|November 21, 2013
Micronuclei in cord blood lymphocytes and associations with biomarkers of exposure to carcinogens and hormonally active factors, gene polymorphisms, and gene expression: the NewGeneris cohortDomenico Franco Merlo, Silvia Agramunt, Lívia Anna, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
European Journal of Nutrition|September 23, 2016
Maternal diet during pregnancy and micronuclei frequency in peripheral blood T lymphocytes in mothers and newborns (Rhea cohort, Crete)Cristina O'Callaghan-Gordo, Manolis Kogevinas, Marie Pedersen, et al.
The Lancet. Oncology|May 14, 2017
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trialAlessandro Gronchi, Stefano Ferrari, Vittorio Quagliuolo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2020
Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma GroupsAlessandro Gronchi, Emanuela Palmerini, Vittorio Quagliuolo, et al.
Molecular Cancer Therapeutics|September 23, 2021
Predictive Value of MRP-1 in Localized High-Risk Soft Tissue Sarcomas: A Translational Research Associated to ISG-STS 1001 Randomized Phase III TrialJavier Martin-Broto, Maria Lopez-Alvarez, David S Moura, et al.
Cancer|October 13, 2021
Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trialSandro Pasquali, Emanuela Palmerini, Vittorio Quagliuolo, et al.
Italian Journal of Pediatrics|December 26, 2014
SETIL: Italian multicentric epidemiological case-control study on risk factors for childhood leukaemia, non hodgkin lymphoma and neuroblastoma: study population and prevalence of risk factors in ItalyCorrado Magnani, Stefano Mattioli, Lucia Miligi, et al.
JAMA Internal Medicine|October 20, 2020
Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical TrialCarlo Salvarani, Giovanni Dolci, Marco Massari, et al.
American Journal of Industrial Medicine|October 19, 2023
Cause specific mortality in an Italian pool of asbestos workers cohortsDaniela Ferrante, Alessia Angelini, Fabiano Barbiero, et al.
The European Respiratory Journal|April 1, 2022
Intravenous methylprednisolone pulses in hospitalised patients with severe COVID-19 pneumonia: a double-blind, randomised, placebo-controlled trialCarlo Salvarani, Marco Massari, Massimo Costantini, et al.
Environmental Health Perspectives|November 21, 2013
Micronuclei in cord blood lymphocytes and associations with biomarkers of exposure to carcinogens and hormonally active factors, gene polymorphisms, and gene expression: the NewGeneris cohortDomenico Franco Merlo, Silvia Agramunt, Lívia Anna, et al.
Pageof 6